Effectiveness of External Vibration for Pain Relief During Intravenous Access in Adult Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03619135 |
|
Recruitment Status :
Completed
First Posted : August 7, 2018
Results First Posted : February 5, 2019
Last Update Posted : February 5, 2019
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
A large number of dentoalveolar (tooth extraction) procedures performed by Oral and Maxillofacial Surgeons utilize intravenous sedation. Procedures commonly performed may include surgical removal of teeth, bone grafting, surgical placement of dental implants, and removal of cysts or tumors from the jaws, among others. Obtaining peripheral intravevenous (IV) cannulation often proves to be a very stressful and anxious event for the patient. The anxiety and stress from the venipuncture alone affects not only the psychological stability of the patient, but also the patient's physiology. The Buzzy vibration external stimulation device has shown to be an effective tool in pediatric venipunture procedures. The aim of this study is to investigate the effects of the Buzzy stimulation device in pain and anxiety reduction during peripheral intravenous cannulation in an adult population.
Enrollees in this study will be patients who will undergo dental surgery with intravenous sedation. The patients who are enrolled will receive an IV either with or without the Buzzy. The Buzzy is a small vibration device which will be placed next to the IV placement site.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Pain Management Anxiety | Device: Buzzy Other: Placebo | Not Applicable |
The participants will be randomized into two groups, those who use the Buzzy system (experimental), and routine IV start (control). Prior to knowing their group, all patients will answer the "Before Intravenous Catheterization" portion of the form in order to eliminate bias. After this portion is complete, their group (experimental vs control) will be determined from opening a blinded envelope.
A tourniquet will be placed, followed by the Buzzy stimulation device (if in the experimental group). An alcohol swab will be used and then a 22 gauge IV catheter will be inserted, connected to fluids, and secured with tape. The antecubital fossa or the dorsal hand/wrist will be the only sites used in the study. All participants will fill out the post-insertion questions on the form and those patients that used the Buzzy system will then fill out the several specific questions related to the experimental group. This will conclude the patient's involvement in the study. The patient will then continue with treatment as planned. We will plan to exclude cases where the IV is not obtained on the first attempt, if a smaller or larger gauge IV catheter is required, or if an insertion site not listed above is required. The case will be excluded if adjunctive steps are taken to obtain IV access (i.e. Oral sedation, nitrous oxide, heat packs).
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 100 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Effectiveness of External Vibration for Pain Relief During Peripheral Intravenous Cannulation in Adult Patients |
| Actual Study Start Date : | October 17, 2016 |
| Actual Primary Completion Date : | August 24, 2017 |
| Actual Study Completion Date : | August 24, 2017 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Use of Buzzy Device
The Buzzy device was used for IV access for this arm.
|
Device: Buzzy
The Buzzy is a reusable device that applies vibration to the skin surface to override the body's gate control pain pathway. It has been used effectively to reduce the discomfort of intravenous cannulation (IV placement) in pediatric patients. Also, it has been utilized to reduce the discomfort of injections in pediatric and adult patients. We are preforming this study to evaluate the effectiveness of the Buzzy in reducing the discomfort associated with intravenous cannluation (IV placement) in adults. |
|
Placebo Comparator: Control
No Buzzy device was used - standard IV access for this arm.
|
Other: Placebo
No use of the Buzzy (standard IV access techniques) |
- Change in Pain [ Time Frame: Baseline and after IV access ]Pain is measured on a 10 point visual analog scale with 0 being no pain and 10 being the worst pain imaginable. A higher score is a worse outcome.
- Change in Anxiety [ Time Frame: Baseline and after IV access ]Anxiety is measured on a 10 point visual analog scale with 0 being no anxiety and 10 being the worst anxiety imaginable. A higher score is a worse outcome.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 40 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Ages 18 and 40.
- Eligible for third molar removal with sedation.
Exclusion Criteria:
- Not eligible for surgery.
- Not eligible for sedation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03619135
| United States, Iowa | |
| University of Iowa College of Dentistry | |
| Iowa City, Iowa, United States, 52242 | |
| Principal Investigator: | Kyle M Stein, DDS, FACS | University of Iowa |
Documents provided by Kyle Stein, University of Iowa:
| Responsible Party: | Kyle Stein, Principal Investigator, University of Iowa |
| ClinicalTrials.gov Identifier: | NCT03619135 |
| Other Study ID Numbers: |
201601806 |
| First Posted: | August 7, 2018 Key Record Dates |
| Results First Posted: | February 5, 2019 |
| Last Update Posted: | February 5, 2019 |
| Last Verified: | January 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | Yes |
| Product Manufactured in and Exported from the U.S.: | Yes |
|
Pain Anxiety intravenous access |

